A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)
Clinical trial NCT04509622 · COMPLETED
Trial details
- NCT number
- NCT04509622
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-05
- Primary completion
- 2021-04-15
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.